KNBWY
KIRIN BREWERY LTD SPONSORED ADRKNBWY
KNBWY
Delisted
KNBWY was delisted on the 29th of June, 2006.
Financial journalist opinion
Positive
Seeking Alpha
2 days ago
Kirin Holdings: Q1 Performance Had Mixed Takeaways
I remain Neutral on Kirin Holdings, as both positives and negatives emerged from the latest quarterly results. 1Q25 operating income grew by a reasonably strong 10%, but this was helped by non-recurring items. Kirin's domestic beverage segment didn't do as well as its key competitors; but there were improvements with its Oceania beer and health science divisions.
Positive
Zacks Investment Research
2 months ago
KNBWY vs. BUD: Which Stock Is the Better Value Option?
Investors with an interest in Beverages - Alcohol stocks have likely encountered both Kirin Holdings Co. (KNBWY) and Anheuser-Busch Inbev (BUD). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
2 months ago
Are Investors Undervaluing Kirin (KNBWY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Positive
Zacks Investment Research
3 months ago
KNBWY or BUD: Which Is the Better Value Stock Right Now?
Investors with an interest in Beverages - Alcohol stocks have likely encountered both Kirin Holdings Co. (KNBWY) and Anheuser-Busch Inbev (BUD). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
3 months ago
Is Kirin (KNBWY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
Business Wire
3 months ago
Kirin Holdings: Improving The Sustainability Of Black Tea Farms In Sri Lanka Through The Regenerative Tea Scorecard In Conjunction With The Rainforest Alliance
TOKYO--(BUSINESS WIRE)--Kirin Holdings Company, Ltd. (Kirin Holdings) (TOKYO: 2503) and Kirin Beverage Company, Ltd. (Kirin Beverage) have been working with the Rainforest Alliance since October 2023 to develop a tool to encourage a transition to regenerative agriculture*1. The Regenerative Tea Scorecard, a tool to encourage the transition to regenerative agriculture, which has been developed in collaboration with the Rainforest Alliance since October 2023, is to be operational from December 20.
Neutral
Business Wire
3 months ago
Kirin Holdings: Conducting Human Rights Due Diligence For Sustainable Sourcing Of Sri Lankan Tea Leaves
TOKYO--(BUSINESS WIRE)--Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO:2503) and Mitsui Norin Co., Ltd. (Mitsui Norin) are developing a human rights due diligence initiative targeting tea plantations in Sri Lanka, with the aim of achieving sustainable sourcing of black tea leaves used for Kirin Gogo-no-Kocha. Kirin Holdings and Mitsui Norin have been implementing the Designated Tea Estates System, under which tea leaves are procured and supplied from designated estates in order to cult.
Positive
Zacks Investment Research
3 months ago
KNBWY vs. DEO: Which Stock Is the Better Value Option?
Investors interested in stocks from the Beverages - Alcohol sector have probably already heard of Kirin Holdings Co. (KNBWY) and Diageo (DEO). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Zacks Investment Research
3 months ago
Should Value Investors Buy Kirin (KNBWY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
Seeking Alpha
7 months ago
Kirin Holdings: More Patience Is Required
My Hold rating for Kirin Holdings is unchanged due to the company's mixed progress relating to diversification beyond the core beverages business, with the pharmaceuticals business growing well and Kyowa Hakko Bio struggling. Kyowa Hakko Bio's revenue decreased by -3% YoY with a wider operating loss in 1H 2024, and this business is expected to continue its underperformance for 2H 2024. The pharmaceuticals segment witnessed a +17% YoY revenue growth in 1H 2024 driven by its Crysvita product, and this segment has both organic and inorganic growth drivers.
Charts implemented using Lightweight Charts™